Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05921071

Do Patients Who Received Tranexamic Acid in Vaginal Hysterectomy Loose Les Blood, Comparing to Patients Who Did Not?

Do Patients Who Are Treated With Tranexamic Acid Loose Les Blood, Comparing to Patients Who Are Not Treated, During Vaginal Hysterectomy? a Randomized Control Study

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Wolfson Medical Center · Other Government
Sex
Female
Age
Healthy volunteers
Accepted

Summary

This is a randomized control, double-blind study in which women who are about to go an elective vaginal hysterectomy are offered to participate. Patients will be randomly assigned to one of two groups: the tranexamic acid group, in which 1 gram of tranexamic acid (Hexakapron) is administered intravenously before surgery, and the control group, in which patients will receive 10 ml of normal saline 0.9% intravenously.

Detailed description

This is a randomized control, double-blind study in which women who are about to go for an elective vaginal hysterectomy are offered to participate. Patients will be randomly assigned to one of two groups: the tranexamic acid group, in which 1 gram of tranexamic acid (Hexakapron) is administered intravenously before surgery, and the control group, in which patients will receive 10 ml of normal saline 0.9% intravenously. A nurse will prepare the solution according to the randomization and will handle it to the anesthesiologist.

Conditions

Interventions

TypeNameDescription
DRUGTranexamic acidOne gram of tranexamic acid (Hexakapron) is administered intravenously before surgery
DRUGPlacebopatients will receive 10 ml of normal saline 0.9% intravenously.

Timeline

Start date
2023-01-22
Primary completion
2024-06-01
Completion
2025-01-01
First posted
2023-06-27
Last updated
2024-04-23

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT05921071. Inclusion in this directory is not an endorsement.